Interstitial lung disease due to polymyositis or dermatomyositis: effect of a 6-month course of i.v. pulse cyclophosphamide.
Meyer
O
O
Hayem
G
G
Palazzo
E
E
Crestani
B
B
Debray
M P
MP
Ballard
M
M
D000328:Adult; D003520:Cyclophosphamide / Q000008:administration & dosage*; D003882:Dermatomyositis / Q000150:complications*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D017563:Lung Diseases, Interstitial / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D008875:Middle Aged; D017285:Polymyositis / Q000150:complications*; D020551:Pulse Therapy, Drug; D012189:Retrospective Studies; D016896:Treatment Outcome
D007166:Immunosuppressive Agents; D003520:Cyclophosphamide